As C.E.O, Mr. Hyun Jong Kim is managing a consulting firm that provides advise Korean healthcare company to advance into the US healthcare market. While he worked for diagnostic company, he has extensive experience in the US healthcare value chain and regulations. He expanded his healthcare knowledge and career through Harvard Medical School healthcare program. As the president of KAPAL CA, a non-profit organization, Mr. Kim led Korean scientists in California, and helped Korean biotechnology companies. He advises Korean startups on the company’s roadmap including market research, financial strategy, IPO, and capital raising. Now, he is involved in a US Nasdaq listing project of a Korean company with a market capitalization of more than $500 million. He also works as a venture partner in a US venture capital fund. He accumulated financial experience in the global financial market for more than 15 years at the Bank of Korea, the Korean central bank. He was responsible for investing $300 billion in global asset markets. After moving to a private company, as executive officer, he experienced IPO in Kosdaq and conducted company operation, financing, investment, and M&A. Mr. Kim successfully completed a BA in Finance and Economics in Yonsei University in Korea, an MBA from Washington University in St. Louis Olin business school and recently graduated from Harvard Medical School GHLP in the US.